CDMO Albany Molecular Research Inc., which was recently acquired by private investors, has bulked up its aseptic API capacity.
Here's your pharma manufacturing news of note.
AmerisourceBergen will extend its reach with an $815 million deal to buy independent drug distributor H. D. Smith.
With its global expansion dragging on earnings, Swedens Recipharm will will close two plants in Sweden and lay off 225 workers.
Budding CDMO Avara Pharmaceutical Services has bought a solid dose facility in France from AstraZeneca, its third plant acquisition in three months.
Swiss CDMO Lonza said it has purchased a clinical-stage manufacturing site in Hayward, California, from Shire.
Investors have had a pointed question for Credit Suisse analysts lately: Is Pfizer buying Bristol-Myers Squibb a question of when, not if?
Catalent has agreed to pay $950 million to buy Cook Pharmica and its extensive biologics manufacturing operation in Bloomington, Indiana.
China’s 3SBio, in a joint venture with CPE Funds, seeks to buy Canadian CDMO Therapure Biomanufacturing for $290 million pending shareholder approval.
Pharma giant Roche has completed the sale of its solid and liquid formulation facility in Segrate, Italy, to CMO Delpharm, which reached a deal to supply the…